Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection

Nature Medicine

Volumn 2, Issue 10, 1996, Pages 1116-1121

  Whittum Hudson, Judith A ^a   An, Ling Ling ^b,d   Saltzman, W Mark ^c,e   Prendergast, Robert A ^a   Macdonald, A Bruce ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c Johns Hopkins University   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; IMMUNIZATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; GLYCOLIPIDS; HUMANS; MICE; MICE, INBRED BALB C; POLYSACCHARIDES, BACTERIAL; TRACHOMA; VACCINATION;

ANIMALIA; CHLAMYDIA TRACHOMATIS; MURINAE;

EID: 0029797560     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1096-1116     Document Type: Article

References (55)

1. Schachter, J. & Dawson, C.R. The epidemiology of trachoma predicts more blindness in the future. Scand. J. Infect. Dis. 69 (Suppl.), 55-62 (1990).
2. Piot, P., Van den Hoek, A.R., Van Damme, L. & Laga, M. Epidemiology and control of genital chlamydial infections. in Chlamydial Infections. (eds. Orfila, J. et al.) 7-15 (Societa Editrice Esculapio, Bologna, 1994).
3. Taylor, H.R. et al. An animal model of trachoma. II. The importance of repeated reinfection. Invest. Ophthalmol. Vis. Sci. 23, 507-515 (1982).
4. Weström L. & Wölner-Hanssen, P. Pathogenesis of pelvic inflammatory disease. Genitourin. Med. 69, 9-17 (1993).
5. Stephens, R.S., Wagar, E. & Schoolnik, G. High resolution mapping of serovarspecific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med. 167, 817-831 (1988).
6. Newhall, W.J., V., Batteiger, B. & Jones, R.B. Analysis of human serological responses to proteins of Chlamydia trachomatis. Infect. Immun. 38, 1181-1189 (1982).
7. Wagar, E. A., Schachter, J., Bavoil, P. & Stephens, R.S. Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J. Infect. Dis. 162, 922-927 (1990).
8. Ting, L., Hsia, R., Haidaris, C.G. & Bavoil, P.M. Interaction of outer envelope proteins of Chlamydia psittaci GPIC with the HeLa cell surface. Infect. Immun. 63, 3600-3608 (1995).
9. Brunham, R.C. et al. Post-abortal Chlamydia trachomatis salpingitis: Correlating risk with antigen-specific responses and with neutralization. J. Infect. Dis. 155, 749-755 (1987).
10. Campos, M. et al. An extract of the major outer membrane protein of Chlamydia trachomatis as a trachoma vaccine candidate. Invest. Ophthalmol. Vis. Sci. 36, 1477-1491 (1995).
11. Batteiger, B.E., Rank, R.G., Bavoil, P.M. & Soderberg, L.S.F. Partial protection against genital reinfection by immunization of guinea pigs with isolated outer membrane proteins of the chlamydial agent guinea pig inclusion conjunctivitis. J. Gen. Microbiol. 139, 2965-2972 (1993).
12. An, L.L. Production and characterization of anti-idiotypic antibodies, biological mimicry of a glycolipid exoantigen of Chlamydia trachomatis in vivo. Ph.D. dissertation, Univ. Massachusetts, Amherst (1993).
13. Stuart, E.S. & MacDonald, A.B. Identification of two fatty acids in a group determinant of Chlamydia trachomatis. Curr. Microbiol. 11, 123-128 (1984).
14. Stuart, E.S., Wyrick, P.B., Choong, J., Stoler, S.B. & MacDonald, A.B. Examination of chlamydial glycolipid with monoclonal antibodies: Cellular distribution and epitope binding. Immunology 74, 740-747 (1991).
15. Stuart, E.S., Tirrell, S.M. & MacDonald, A.B. Characterization of an antigen secreted by chlamydial infected cell culture. Immunology 61, 527-533 (1987).
16. Wyrick, P. et al. Chlamydia trachomatis antigens on the surface of human endometrial cells. Immunol. Infect. Dis. 4, 131-141 (1994).
17. Stuart, E.S., Troidle, K.M. & MacDonald, A.B. Chlamydial glycolipid antigen: Extracellular accumulation, biological activity, and antibody recognition. Curr. Microbiol. 28, 85-90 (1994).
18. Stuart, E.S. & MacDonald, A.B. Some characteristics of a secreted chlamydial antigen recognized by IgG from Chlamydia trachomatis patient sera. Immunology 68, 469-473 (1989).
19. Schachter, J. Overview of Chlamydia trachomatis infection and the requirements for a vaccine. Rev. Infect. Dis. 7, 713-716 (1985).
20. Michalek, S.M. et al. The IgA response: Inductive aspects, regulatory cells, and effector functions. Ann. N.Y. Acad. Sci. 409, 48-71 (1983).
21. Pal, S., Pu, Z., Huneke, R.B., Taylor, H.R. & Whittum-Hudson, J.A. Chlamydia-specific lymphocytes in conjunctiva during ocular infection: Limiting dilution analysis. Reg. Immunol. 3, 171-176 (1990).
22. Rank, R.G. & Sanders, M.M. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am. J. Pathol. 140, 927-936 (1992).
23. Reacher, M.H., Pe'er, J., Rapoza, P.A., Whittum-Hudson, J.A. & Taylor, H.R. T-cells and trachoma: Their role in cicatricial disease. Ophthalmology 98, 334-341 (1991).
24. Cain, T.K. & Rank, R.G. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 63, 516-521 (1995).
25. + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 63, 3302-3308 (1995).
26. Rolf, J.M., Gaudin, H.M., Tirrell, S.M., MacDonald, A.B. & Eidels, L. Anti-idiotypic antibodies that protect cells against the action of diphtheria toxin. Proc. Natl. Acad. Sci. USA 86, 2036-2039 (1989).
27. Nisonoff, A. & La Moyi, E. Implications of the presence of an internal image of the antigen in anti-Id antibodies: Possible application to vaccine production. Clin. Immunol. Immunopathol. 21, 397-403 (1981).
28. Stein, K.E. Network regulation of the immune response to bacterial polysaccharide antigens. Curr. Top. Microbiol. Immunol. 119, 57-74 (1985).
29. Kennedy, R.C., Dreesman, G.R. & Kohler, H. Vaccines utilizing internal image anti-idiotypic antibodies that mimic antigens of infectious organisms. BioTechniques 3, 404-409 (1985).
30. Su, S., Ward, M.M., Apicella, M.A. & Ward, R.E. A nontoxic, idiotope vaccine against gram-negative bacterial infections. J. Immunol. 148, 234-238 (1992).
31. Hawkins, R.E., Winter, G., Hamblin, T.J., Stevenson, F.K. & Russell, S.J. A genetic approach to idiotypic vaccination. J. Immunother. 14, 273-278 (1993).
32. Eldridge, J., Hammond, C., Meulbroek, J., Gilley, R. & Tice, T. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Controlled Release 11, 205-214 (1990).
33. Challacombe, S., Rahman, D., Jeffery, H., Davis, S. & O'Hagan, D. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76, 164-168 (1992).
34. Marx, P.A. et al. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260, 1323-1327 (1993).
35. Whittum-Hudson, J.A., O'Brien, T.P. & Prendergast, R.A. Murine model of ocular infection by a human biovar of Chlamydia trachomatis. Invest. Ophthalmol. Vis. Sci. 36, 1976-1987 (1995).
36. Blanchard, T.G., An, L., Troidle, K.M., Tirrell, S.M. & MacDonald, A.B. Internal image of exoglycolipid genus-specific antigen produced by anti-idiotype. In Chlamydial Infections (eds. Bowie, W.R. et al.) 205-208 (Cambridge Univ. Press, Cambridge, 1990).
37. Troidle, K.M. Characterization of a genus-specific chlamydial antigen. Ph.D. thesis, Univ. Massachusetts, Amherst (University Microfilms, Ann Arbor, Michigan, 1992).
38. Scieux, C. et al. Evaluation of a new chemiluminometric immunoassay, Magic Lite Chlamydia, for detecting Chlamydia trachomatis antigen from urogenital specimens. Sex. Transm. Dis. 19, 161-164 (1992).
39. Murdin, A.D., Su, H., Klein, M.H. & Caldwell, H.D. Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infect. Immun. 63, 1116-1121 (1995).
40. Su, H., Parnell, M. & Caldwell, H.D. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: Serum neutralizing antibodies do not protect against chlamydial genital tract infection. Vaccine 13, 1023-1032 (1995).
41. Brossay, L. et al. Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies. Infect. Immun. 62, 341-347 (1994).
42. Jerne, N.K. Towards a network theory of the immune system. Ann. Immunol. (Inst. Pasteur) 125C, 373-389 (1974).
43. Fields, B.A., Goldbaum, F.A., Ysern, X., Poljak, R.J. & Mariuzza, R.A. Molecular basis of antigen mimicry by an anti-idiotope. Nature 374, 739-742 (1995).
44. Westerink, M.A. & Apicella, M.A. Anti-idiotypic antibodies as vaccines against carbohydrate antigens [Review]. Springer Semin. Immunopathol. 15, 227-234 (1993).
45. Rees, A.D.M. et al. T cell activation by anti-idiotypic antibody: Mechanism of interaction with antigen-reactive T cell. Eur. J. Immunol. 17, 197-201 (1987).
46. Taylor, H.R., Johnson, S.L., Schachter, J., Caldwell, H.D. & Prendergast, R.A. Pathogenesis of trachoma: The stimulus for inflammation. J. Immunol. 138, 3023-3027 (1987).
47. Kiyono, H. & McGhee, J.R. T helper cells for mucosal immune responses, in Handbook of Mucosal Immunology. (ed. Ogra, P.L.) 263-274 (Academic Press, New York, 1994).
48. Igietseme, J. U. et al. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg. Immunol. 5, 317-324 (1993).
49. Magee, D.M. et al. Role of CD8 T cells in primary chlamydia infection. Infect. Immun. 63, 516-521 (1995).
50. Harlow, E. & Lane, D. The Antibodies, 139-243 (Cold Spring Harbor Press, Cold Spring Harbor, New York, 1994).
51. Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. & Langer, R. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res. 8, 713-720 (1991).
52. Salehi-Had, S. & Saltzman, W. M. Controlled intracranial delivery of antibodies in the rat, in Protein Formulations and Delivery, (eds. Cleland, J. & Langer, R.) 278-298 [ACS (Am. Chem. Soc.) Symp. Series, Washington, DC, 1994].
53. Salehi-Had, S. & Saltzman, W. M. Controlled intracranial delivery of antibodies in the rat, in Protein Formulations and Delivery, (eds. Cleland, J. & Langer, R.) 278-298 [ACS (Am. Chem. Soc.) Symp. Series, Washington, DC, 1994].
54. Taylor, H.R., Agarwala, N. & Johnson, S.L. Detection of experimental Chlamydia trachomatis eye infection in conjunctival smears and in tissue culture by use of fluorescein-conjugated monoclonal antibody. J. Clin. Microbiol. 20, 391-395 (1984).
55. Byrne, G.I. et al. Workshop on in vitro neutralization of Chlamydia trachomatis: Summary of proceedings. J. Infect. Dis. 168, 415-420 (1993).